Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-11-29, 09:17:25 | version 1.38.0
exhibitors 20 Greater New York Dental Meeting — Nov. 29, 2016 Ad By St. Renatus Staff n St. Renatus, LLC, a privately held companybasedinFortCollins,Colo.,is nowtakingordersforitsfirstproduct, a new dental anesthetic, Kovanaze™ (tetracaine HCl and oxymetazoline HCl)NasalSpray.VisitBoothNo.5040 ontodayandWednesdayforhands-on Kovanaze training demonstrations, 15-minute information presentations andtheopportunitytoorderyourfirst box(es). “Our team is excited and fully prepared to launch this innovative product into the dental market,” said Judy Persson, St. Renatus’ national sales director. “We encourage all den- talprofessionalstocomebyourbooth (No. 5040) to receive a hands-on dem- onstration of the nasal spray, obtain moreinformationonwhythisproduct can be an alternative to needle injec- tions and how it can be implemented into their practice.” KovanazeisthefirstFDA-approved productthatallowsformaxillaryden- tal anesthesia of teeth Nos. 4-13 or A-J via nasal spray versus needle and is indicated for restorative procedures in patients 40kg or above. Dental professionals can learn more about Kovanaze and place orders at the St. Renatus Booth (No. 5040), learn more at www.kovanaze. com or call the Kovanaze Support Line at (800) 770-9400. Order new nasal spray anesthetic Kovanaze today Here in New York To learn more about Kovanaze and place orders, visit St. Renatus at booth No. 5040. You can also learn more at www.kovanaze.com or call Kovanaze support at (800) 770-9400. 5 New nasal spray anesthetic Kovanaze can be ordered here at the GNYDM. (Photo/Provided by St. Renatus)